Le Lézard
Classified in: Business
Subject: ATY

RVNC EQUITY ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors with Losses to Inquire About Class Action Investigation - RVNC


NEW YORK, Oct. 18, 2021 /PRNewswire/ --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC) resulting from allegations that Revance may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Revance securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to http://www.rosenlegal.com/cases-register-2179.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: On October 12, 2021, the U.S. Food and Drug Administration (FDA) posted Form 483 to its website citing issues found during the inspection of a Revance facility in July 2021. The FDA noted a working cell bank as a cause of rejected GMP lots of a product, discrepancies between the manufacturing process compared to that proposed for licensure, and said the Company's quality unit "lacks the responsibility and authority for the control, review, and approval of outsourced activities...".

On this news, Revance share prices dropped $6.85, or over 25%, to close at $20.45 on October 12, 2021.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Revance: https://www.Revance.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      cases@rosenlegal.com
      www.rosenlegal.com

SOURCE Rosen Law Firm, P.A.


These press releases may also interest you

at 07:30
Salona Global Medical Device Corporation ("Salona" or the "Company") , an acquisition-oriented medical device company serving the global injury and surgery recovery (known as recovery science) market, has launched a new U.S. sales subsidiary, formed...

at 07:30
Purpose Investments Inc. ("Purpose Investments" or "Purpose") today announced the launch of the world's first covered call and actively managed cryptocurrency ETFs: Purpose Bitcoin Yield ETF, Purpose Ether Yield ETF, and Purpose Crypto Opportunities...

at 07:30
Amerigo Resources Ltd. ("Amerigo" or the "Company") is pleased to announce that the Toronto Stock Exchange (the "TSX") has accepted Amerigo's application for a normal course issuer bid (the "NCIB"). Under the NCIB Amerigo may purchase up...

at 07:30
ECMOHO Limited ("ECMOHO", "we" or the "Company"), an integrated solutions provider in the health and wellness market in China, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021...

at 07:30
ParcelPal Logistics Inc. (the "Company" or "ParcelPal"), is pleased to announce that as part of the Company's broader plan to continue to diversify its customer base and execute on additional profitable business engagements, it has signed another...

at 07:30
Manulife Investment Management today announced the 2021 annual reinvested distribution estimates for Manulife Exchange Traded Funds (ETFs). These annual reinvested distributions generally represent realized capital gains within the ETFs. Please note...



News published on 18 october 2021 at 20:23 and distributed by: